Statistics
Publications
36
Citations
4.2K
H-Index
27
Active since
1991
Mark G. Anderson is an author at Abbott Fund specializing in life sciences, oncology, and molecular biology.
Publications per year
1991–2023
36
36
ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
Christin Tse, Alexander R. Shoemaker, Jessica Adickes et al. · Cancer Research · 2008 · 2K citations · Full text
Medicine, Oncology, Pharmacology +16
Expression of VDR and CYP24A1 mRNA in human tumors
Mark G. Anderson, Masaki Nakane, Xiaoan Ruan et al. · Cancer Chemotherapy and Pharmacology · 2005 · 241 citations
Dharam P. Sharma, M. Christine Zink, Mark G. Anderson et al. · Journal of Virology · 1992 · 176 citations · Full text
Jieyi Wang, Mark G. Anderson, Anatol Oleksijew et al. · Clinical Cancer Research · 2016 · 140 citations · Full text
Medicine, Oncology, Pharmacology +16
1–5 of 36